Mapping the in vivo distribution of herpes simplex virions.
We describe a method for labeling enveloped viral particles with a radiotracer, indium-111, allowing labeled viruses to be traced in vivo by nuclear imaging. After initial optimization experiments, a labeling efficiency of 83% (incorporation yield) was achieved for herpes simplex virus (HSV), resulting in a specific activity of 30 microCi/10(9) PFU. The labeling procedure did not significantly reduce the infectivity of the labeled virus and the virus did not release any significant amounts of the radionuclide within 12 hr after labeling. Sequential imaging of animals after intravenous administration of the labeled virus showed fast accumulation in the liver and redistribution from the blood pool (immediately after injection) to liver and spleen (12-24 hr after injection). At 12 hr after injection 7% of the virus-associated (111)In had been eliminated from the body and the remaining organ distribution of the virus was as follows: spleen 2.87 +/- 0.54% ID/g; liver, 2.60 +/- 0.51% ID/g; kidney, 0.98 +/- 0.31% ID/g; lung, 0.57 +/- 0.10% ID/g; [corrected] and lower amounts in other organs. Our results indicate that the described method allows qualitative and quantitative assessment of viral biodistribution in vivo by nuclear imaging.
Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Charlestown 02129, USA.
D
D
Schellingerhout
A
A
Bogdanov
E
E
Marecos
M
M
Spear
X
X
Breakefield
R
R
Weissleder
D000818:Animals; D015316:Genetic Therapy; D005822:Genetic Vectors; D006561:Herpes Simplex / Q000000981:diagnostic imaging*; D006801:Humans; D007205:Indium Radioisotopes; D007275:Injections, Intravenous; D008099:Liver / Q000821:virology; D011877:Radionuclide Imaging; D051381:Rats; D018139:Simplexvirus / Q000235:genetics / Q000502:physiology*; D013154:Spleen / Q000821:virology; D014018:Tissue Distribution; D014771:Virion
D007205:Indium Radioisotopes